share_log

4: Statement of changes in beneficial ownership of securities-Officer Kupiec James William

4: Statement of changes in beneficial ownership of securities-Officer Kupiec James William

4:持股变动声明-高管 Kupiec James William
美股SEC公告 ·  09/09 17:46

Moomoo AI 已提取核心信息

James William Kupiec, the Chief Medical Officer of Cassava Sciences Inc. (ticker: SAVA.US), was involved in a transaction with the company's stock on September 6, 2024. The specific details of the transaction, such as the action type, status, number of shares, nature of shares, transaction price, and total value, were not disclosed in the announcement. As a result, the impact of this event on Kupiec's holdings and the overall market perception of Cassava Sciences remains unclear.
James William Kupiec, the Chief Medical Officer of Cassava Sciences Inc. (ticker: SAVA.US), was involved in a transaction with the company's stock on September 6, 2024. The specific details of the transaction, such as the action type, status, number of shares, nature of shares, transaction price, and total value, were not disclosed in the announcement. As a result, the impact of this event on Kupiec's holdings and the overall market perception of Cassava Sciences remains unclear.
2024年9月6日,Cassava Sciences Inc.(股票代码:SAVA.US)的首席医疗官詹姆斯·威廉·库皮克参与了一项交易。交易的具体细节,如操作类型、状态、股票数量、股票性质、交易价格和总价值,在公告中未披露。因此,这一事件对库皮克的持股情况以及对Cassava Sciences整体市场认知的影响尚不清楚。
2024年9月6日,Cassava Sciences Inc.(股票代码:SAVA.US)的首席医疗官詹姆斯·威廉·库皮克参与了一项交易。交易的具体细节,如操作类型、状态、股票数量、股票性质、交易价格和总价值,在公告中未披露。因此,这一事件对库皮克的持股情况以及对Cassava Sciences整体市场认知的影响尚不清楚。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息